Search results
Found 9282 matches for
Kennedy Professor leads Cellular Life Theme of Reuben College
1 July 2020
Professor Mark Coles was recently appointed to the governing body of the University’s newest graduate college.
Joint cell discovery offers new hope for people with rheumatoid arthritis
29 June 2020
The key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.
Sir Marc Feldmann awarded the 2020 Tang Prize in Biopharmaceutical Science
Awards
22 June 2020
Recognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.
NDORMS professor awarded prestigious Carol Nachman prize for Rheumatology
Awards
17 June 2020
Christopher Buckley, Kennedy Professor of Translational Rheumatology at the University of Oxford and Birmingham, has been awarded the 2020 Carol Nachman prize for Rheumatology.
Oxford leads part of major COVID-19 drugs trial
10 June 2020
The Arthritis Therapy Acceleration Programme (A-TAP), led by the Kennedy Institute in Oxford and the Institute of Inflammation and Ageing in Birmingham, provides support for the new CATALYST Trial to investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death.
New atlas of stromal cells maps out potential for treating human fibrosis
4 June 2020
Research at the Kennedy Institute reveals sub-populations of stromal cells with distinct functions in human fibrotic disease. These findings could inform development of more specific therapies with fewer off-target effects.
Understanding of inflammatory bowel disease moves a step closer
23 May 2020
Published in Science Immunology, researchers at the Kennedy Institute have identified the role of IRF5 in controlling intestinal inflammation.
Dr. Michael Dustin joins Strategic Research Collaboration with Cue Biopharma
14 May 2020
The research will test innovative technology that harnesses the body’s intrinsic immune system to transform the treatment of cancer and autoimmune diseases.
New weapon identified in arsenal against disease
11 May 2020
Researchers in the Dustin Group reveal supramolecular attack particles are autonomous killing entities released from cytotoxic T lymphocytes
The NDORMS response to COVID-19
30 April 2020
A number of members of the department are actively helping with the response to the COVID pandemic. Playing a key role in research, literature reviews, clinical trials and engineering projects, all have a shared commitment to collaborate globally to tackle the pandemic.
Professor Fiona Powrie elected to the National Academy of Sciences in the USA.
Department
29 April 2020
Fiona was recognised for her outstanding contributions to immunology, and her election brings the number of current National Academy of Sciences members from the Kennedy Institute to three.
Live imaging shows surprising passage of T cells in the spleen
16 April 2020
Research from Tal Arnon’s group at the Kennedy Institute reveals a network of perivascular pathways that guide T cells into the spleen.
Coronavirus information - what we are doing at NDORMS to support our staff and students and the community
Department
20 March 2020
NDORMS announces the closure of the Kennedy and Botnar Institutes and outlines other plans and activities for the department during the pandemic.
Researchers identify markers in joint fluid that could be the key to cartilage repair
General
9 March 2020
Molecular changes in the joint fluid during surgical joint distraction reveal markers that may drive cartilage repair in osteoarthritis.
CRUK success for NDORMS researchers
Funding
21 February 2020
Investigators based at the Kennedy Institute of Rheumatology, NDORMS have recently received CRUK awards to increase understanding of a variety of cancers and immunotherapy.
Two new Associate Professors at NDORMS
31 January 2020
Dr Fiona Watt and Professor Stephanie Dakin announced as Associate Professors
New collaboration will help researchers understand why cancer survival between patients differs
27 January 2020
NDORMS researchers join five other universities to investigate how cancer survivors make antibodies that target and destroy tumours, and explore routes for new treatments
New therapeutic target identified in spondyloarthritis
20 January 2020
A new study published in Nature Communications identifies a key driver of joint and intestinal inflammation that could lead to future treatment of the chronic inflammatory disease.